Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2011-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main hypotheses (H1):
* The nutraceutical has an impact on oxidative stress reduction.
* The nutraceutical has an impact on inflammation.
* The nutraceutical has an impact on blood flow and microcirculation.
* Walking exercise for 30 minutes has an impact on oxidative stress- and inflammation markers.
* Walking exercise for 30 minutes has an impact on blood flow and microcirculation
* The combination of nutraceutical supplementation + walking exercise for 30 minutes has an impact on oxidative stress- and inflammation markers, and on blood flow/microcirculation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs
NCT06641596
Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants
NCT04959006
Effect of Beetroot Juice Supplements on Lower-limb Strength in Females
NCT04987619
ABG Oxidative Stress Study Protocol-1
NCT02213523
Acquiring and Targeting Heat Exposures Necessary for Action
NCT05678738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fruit, berry and vegetable concentrate
20 ladies receive an encapsulated, powdered fruit, berry and vegetable concentrate for 8 weeks
nutraceutical group
6 capsules of supplement or placebo for 8wk
20 women with placebo
placebo for 8 weeks
nutraceutical group
6 capsules of supplement or placebo for 8wk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nutraceutical group
6 capsules of supplement or placebo for 8wk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 27
* praemenopausal
* non smokers
* eligibility for exercise
* 4wk wash out
Exclusion Criteria
* all people not matching this age group
* BMI \> 40 and \< 27
* peri- or postmenopausal women
* smokers
* all women taking dietary supplements
* all women that fail in ergometric exercise eligibility testing, refering to the standards in sports medicine (e.g.: significant ST-decrease or increase, blood pressure \> 240 mmHg, tachycardia, polymorphic extrasystolia, cyanosis, bradyarrhythmia..)
* Diabetics
* osteoporosis or osteopenia
35 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Green Beat
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lamprecht Manfred PhD, PhD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manfred Lamprecht, PhD PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Graz
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-508 ex 10/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.